Emilee Survance, DO
Sleep Medicine · Seymour, INNPI 1619406089
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,302 of the $2,642 with a category attached, or 87.1%. 21 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 45.4% of the total.
Across 104 payments — averaging $25.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$1K
- Avadel CNS Pharmaceuticals, LLC$217
- GSK$171
- Axsome Therapeutics, Inc.$137
- Resmed Corp$124
- AbbVie$124
- plus $671 from 15 others
What the payments were for
- Consulting fees$1506%
- Food & beverage$2,30287%
- Education$1907%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 31 | $1,199 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $217 |
| GSK | 12 | $171 |
| Axsome Therapeutics, Inc. | 7 | $137 |
| Resmed Corp | 6 | $124 |
| AbbVie | 7 | $124 |
| Lilly USA, LLC | 6 | $91 |
| Novo Nordisk | 6 | $90 |
| Bayer | 4 | $79 |
| Merck | 4 | $79 |
| Itamar Medical Inc | 2 | $59 |
| Inspire Medical Systems, Inc. | 2 | $57 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $30 |
| Exact Sciences | 2 | $28 |
| La Jolla Pharmaceutical Company | 1 | $23 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
| Grifols USA, LLC | 1 | $18 |
| ZOLL Respicardia, Inc. | 1 | $14 |
| Melinta Therapeutics, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,642 in reported general payments places this provider in the 65th percentile of 32 sleep medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 94 | $841 |
| Modafinil | 14 | $471 |
| Ropinirole Hcl | 62 | $370 |
| Armodafinil | 11 | $329 |
| Eszopiclone | 24 | $254 |
| Clonazepam | 16 | $139 |
| Zolpidem Tartrate | 15 | $22 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Seymour
- Shalini ManchandaIndianapolis$43K
- Aaron RobertsFort Wayne$31K
- Sridhar JatlaKokomo$10K
- Douglas LiepertSouth Bend$10K
- Israr SiddiqiElkhart$8K
- Adam LenetIndianapolis$5K
- Alaa ShammahIndianapolis$3K
- Akudo AnokwuteBrownsburg$3K
- Joshua BowlingMishawaka$3K
- Ram VermaFort Wayne$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.